Washington DC [US], July 22 (ANI): Researchers from Rutgers University have found that most persons with multiple sclerosis (MS) opt for oral drugs to manage their chronic and worsening neurological conditions. This is probably because of a number of elements, such as consumer promotion, ease of use, and insurance companies’…Read More
Oral medication leading choice for multiple sclerosis treatment Study
